| 521 |
Novel 2-Indolinone Based derivatives Targeting Cell Cycle Checkpoint’s Proteins as Potential Anticancer Agents |
Department of Medicinal Chemistry |
2021 |
| 522 |
Novel Green Biosynthesis of 5-Fluorouracil Chromium Nanoparticles Using Harpullia pendula Extract for Treatment of Colorectal Cancer |
Department of Industrial Pharmacy |
2021 |
| 523 |
Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen |
Department of Pharmaceutics |
2021 |
| 524 |
Novel Urea Linked Ciprofloxacin-Chalcone Hybrids having Antiproliferative Topoisomerases I/II Inhibitory Activities and Caspases-Mediated Apoptosis |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 525 |
Novel Urea Linked Ciprofloxacin-Chalcone Hybrids having Antiproliferative Topoisomerases I/II Inhibitory Activities and Caspases-Mediated Apoptosis |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 526 |
Performance of simvastatin microsponges as a local treatment for chronic periodontitis – Randomized clinical trial |
Department of Pharmaceutics |
2021 |
| 527 |
Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer’s Disease, in Serum and Tissue of Sprague Dawley Rats |
Department of Pharmacology |
2021 |
| 528 |
Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia |
|
2021 |
| 529 |
Recent updates in COVID-19 with emphasis on inhalation therapeutics: nanostructured and targeting systems |
Department of Industrial Pharmacy |
2021 |
| 530 |
Recent updates in COVID-19 with emphasis on inhalation therapeutics: nanostructured and targeting systems |
Department of Industrial Pharmacy |
2021 |